Joseph P. Bellino
Analyst · Noble Financial
Thanks, Tony, and good day, everyone. Earlier this afternoon, after the market closed, we reported results for the fourth quarter and full year of 2012. For the fourth quarter, sales grew 3% to $194 million as compared to approximately $188 million in last year's fourth quarter. Net income grew to $3.4 million or $0.32 per diluted share compared with $2.8 million or $0.27 per diluted share. Last year's results excluded merger-related expenses and goodwill impairment charges. It's important to note that on our fourth quarter 2012 results, it included a onetime regulatory-driven income tax charge amounting to $2.2 million or $0.21 per diluted share, driving the effective tax rate for the quarter to 48%. This charge resulted from new legislation enacted in the fourth quarter 2012 in the State of California which impacted our ability to take advantage of state research and development tax credits that were already on our balance sheet. In effect, we had to write down this tax asset and thus, recorded a valuation allowance in the amount of the $0.21 per share. The fourth quarter tax rate in 2012 also did not include the benefits of a federal R&D tax credit, which the fourth quarter of 2011, and all previous quarters in our history since about the mid-'80s, reflected such R&D tax credits. As the new legislation was approved in January of 2013, we will record this tax benefit in the first quarter of 2013 in the amount of approximately $2 million, or $0.19 a share. In addition, the legislation provided for the R&D -- federal R&D tax credit to be applicable for the entire year of 2013, and so in addition to taking the $2 million tax credit in the first quarter, we expect to pay an average of 31% effective tax rate here in 2013. Looking at our fourth quarter results, we saw a number of gains in our year-over-year financial performance, including a 28% increase in adjusted EBITDA to nearly $23 million from $17.8 million in 2011. This was driven by higher gross margins and a favorable product mix. In addition, we experienced a significant improvement in working capital efficiency, primarily driven by improved inventory turns, and continued working -- effective working capital management in addition to deleveraging of our balance sheet. And while Ducommun's year-over-year numbers show significant strengthening, we thought it was meaningful, as we have in the last 3 quarters, to talk about sequential improvement when discussing our results. During the fourth quarter, Ducommun's sales, as I mentioned, was $194 million. That increased $10 million from the third quarter's $184 million. As we look at that growth, the sequential sales growth was driven by a combination of increased shipments in both military electronics and AeroStructure products. Operating margins held at 7.6%, roughly the same as the third quarter, and we continue to see sustainable synergies from the LaBarge acquisition. And in addition, we sequentially reduced our SG&A expenses to 10.7% compared to 11.6% in this year -- in 2012's third quarter. During our previous earnings calls, we have discussed our higher operating margins expectations, so we're pleased that they are being sustained at the current levels. In addition, during the fourth quarter, we generated $22.7 million in adjusted EBITDA, or 11.7% of revenues. That compares with $22 million in adjusted EBITDA, or 11.9% as a percentage of revenues, in the third quarter of 2012. Our backlogs grew to a record $657 million. That's 13% higher than when we acquired LaBarge in June of 2011. The backlog at the end of fiscal 2012 primarily reflects increased orders in the military space and commercial aerospace markets and are partially offset by lower bookings in some of our non-aerospace and defense markets. Now if we turn to results by the business segments. First, starting with Ducommun AeroStructures or DAS. DAS sales for the quarter grew sequentially to $82 million from $77 million in the third quarter 2012, as the segment benefited from increased sales of military helicopter products. We spoke earlier about the revenue from large commercial aircraft products. Those build rates continued at high levels in the fourth quarter just as they have been in the third quarter, and it parallels the build rates at the mainframe manufacturers. DAS's adjusted EBITDA for the fourth quarter were approximately $10 million or 12% of sales, 12.6% of sales, was about the same as the third quarter 2012, despite an $800,000 increase -- increases in charges for pension fund expenses, which we recorded here in the fourth quarter. During the quarter, we continued to see reductions in development costs for new programs as compared to the third quarter of 2012, an item we have been closely monitoring and discussing with you throughout the year. Moving to our Ducommun LaBarge Technologies segment, DLT. We posted sales for the quarter of nearly $112 million versus $107 million in the third quarter, with the increase driven primarily by higher electromechanical shipments such as military airborne radar systems and electronics for military helicopters, somewhat offset by softer non-aerospace and defense revenues. For the fourth quarter, DLT's adjusted EBITDA expanded to 16.2% (sic) [$16.2 million] or 14.5% of revenue, up from $15.2 million or 14.1% of revenue in the third quarter. We're really pleased to see, sequentially during the year, that both our adjusted EBITDA dollars and our percentage of revenues expanded in the DLT segment. We continue to benefit from a combination of a favorable product mix, solid management at our DLT operations and cost savings associated with our successful integration efforts. In terms of corporate G&A, those are the costs that aren't allocated by business segment, they ran about 2%, which is about the same as they have been in the third quarter, reflecting good strong cost controls in that area of management. Now turning to liquidity and capital resources. During the quarter, we prepaid an additional $15 million of our debt on top of $10 million in the third quarter. And in the process, we reduced our overall debt to $366 million, and our net debt was reduced to $319 million. Given our full year 2012 adjusted EBITDA of approximately $85 million, this equates to 3.7x net funded debt to EBITDA. As I mentioned before, for the total year, we paid down $25 million in debt, and in '13, we expect to pay down another $25 million to $30 million, with the goal of deleveraging the company to -- by 2015 to a funded debt-to-EBITDA levels ranging from about 2.75x to 3x. In this year's final quarter, we generated a strong $36 million in cash from operations, and for the entire year, we generated $48 million in cash from operations and $32 million in free cash flow. The $32 million in free cash flow equates to about $3 per diluted share. We are driving cash generation from a combination of internal initiatives resulting in higher EBITDA levels, increased inventory returns and overall more effective working capital management. We expect our $60 million revolving credit line to remain unused for the foreseeable future. In terms of capital expenditures, we expect to expand about $15 million in 2013, which is about the same as 2012. Our future capital expenditures are focused on 2 things: expanding of our manufacturing capabilities and supporting our new contract awards. So in closing, we're very pleased with the sequential quarterly improvement throughout the year in our key performance measures, most notably: growth in adjusted EBITDA, operating margins on a sustainable level and strong cash flow generation, as we are benefiting from an improved mix of products, better performance on new program costs and the synergies realized through our integration efforts. I'll now turn the program back over to Tony for his closing remarks. Tony?